Novo CEO pressed by Senate to cut prices of being overweight, diabetes drugs CEO Lars Fruergaard Jørgensen told lawmakers the corporate would think about new talks with insurers regarding the record prices of Wegovy and copyright if they pledge to help keep the medicines on their own formularies. Sanders swiftly https://kethek.com/